[go: up one dir, main page]

MX2022010964A - Composicion que comprende una avenantramida o un analogo de la misma con estabilidad mejorada. - Google Patents

Composicion que comprende una avenantramida o un analogo de la misma con estabilidad mejorada.

Info

Publication number
MX2022010964A
MX2022010964A MX2022010964A MX2022010964A MX2022010964A MX 2022010964 A MX2022010964 A MX 2022010964A MX 2022010964 A MX2022010964 A MX 2022010964A MX 2022010964 A MX2022010964 A MX 2022010964A MX 2022010964 A MX2022010964 A MX 2022010964A
Authority
MX
Mexico
Prior art keywords
composition
analogue
avenantramide
improved stability
cosmetic
Prior art date
Application number
MX2022010964A
Other languages
English (en)
Inventor
Sabine Lange
Martina Herrmann
Holger Joppe
Sebastian Bruncke
Kalpana Palani
Original Assignee
Symrise Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symrise Ag filed Critical Symrise Ag
Publication of MX2022010964A publication Critical patent/MX2022010964A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/445—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere, en general: a una composición que comprende o consiste en al menos una avenantramida o un análogo de la misma o un extracto de avena que comprende una avenantramida o un análogo de la misma con una estabilidad mejorada; su uso cosmético o médico; al uso de dicha composición para la preparación de alimentos, suplementos alimenticios, preparaciones cosméticas, farmacéuticas o veterinarias; y alimentos, suplementos alimenticios, preparaciones cosméticas, farmacéuticas o veterinarias que comprenden dicha composición. Finalmente, la presente invención se refiere a estabilizadores específicos para la estabilización de avenantramida(s).
MX2022010964A 2020-03-06 2020-03-06 Composicion que comprende una avenantramida o un analogo de la misma con estabilidad mejorada. MX2022010964A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2020/056122 WO2021175453A1 (en) 2020-03-06 2020-03-06 Composition comprising an aventhramide or an analogue thereof with improved stability

Publications (1)

Publication Number Publication Date
MX2022010964A true MX2022010964A (es) 2022-10-18

Family

ID=69780214

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022010964A MX2022010964A (es) 2020-03-06 2020-03-06 Composicion que comprende una avenantramida o un analogo de la misma con estabilidad mejorada.

Country Status (9)

Country Link
US (1) US20230131993A1 (es)
EP (1) EP4114348A1 (es)
JP (2) JP2023516453A (es)
KR (1) KR102808076B1 (es)
CN (1) CN115209864A (es)
BR (1) BR112022017573A2 (es)
CA (1) CA3172770A1 (es)
MX (1) MX2022010964A (es)
WO (1) WO2021175453A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4487838A3 (en) * 2020-03-06 2025-04-02 Symrise AG Avenanthramide compositions with improved solubility comprising 4-hydroxyphenone
WO2023245462A1 (en) * 2022-06-21 2023-12-28 L'oreal Stabilized composition comprising thiopyridinone compound
JP2025526989A (ja) * 2022-08-23 2025-08-15 ケンビュー・ブランズ・エルエルシー 湿疹に罹患した皮膚の外観を改善する方法
CA3264265A1 (en) * 2022-08-23 2024-02-29 Kenvue Brands Llc METHODS FOR PROVIDING A COOLING SENSATION TO SKIN SUFFERING FROM ECZEMA
CN119789860A (zh) * 2022-08-23 2025-04-08 科赴品牌有限责任公司 适用于患有湿疹的皮肤的组合物
CN115317386A (zh) * 2022-09-21 2022-11-11 江西沁华蔓医药科技有限公司 提拉紧致抗衰老精华液及其制备方法
FR3143357B1 (fr) * 2022-12-19 2025-09-19 Oreal Composition cosmétique aqueuse avec acide ascorbique et arginine
WO2024150169A1 (en) * 2023-01-11 2024-07-18 Johnson & Johnson Consumer Inc. Compositions comprising a retinoid and a processed oat ingredient
WO2024256011A1 (en) * 2023-06-15 2024-12-19 Symrise Ag Stabilizer or stabilizer composition for stabilizing dihydroavenanthramide d
CN117257663A (zh) * 2023-10-18 2023-12-22 福州美乐莲生物科技有限公司 燕麦生物碱a、b、c组合物及其作为制备化妆品皮肤舒缓剂的用途
KR20250089633A (ko) * 2023-12-11 2025-06-19 코스맥스 주식회사 귀리 추출물 및 보리 추출물을 포함하는 반려동물 피부 보습 또는 항염증용 조성물
CN117717492B (zh) * 2023-12-19 2024-08-20 中山自然说生物科技有限公司 一种修复腋窝微生态的生物制剂及其制备方法和应用
WO2025149755A1 (en) * 2024-01-12 2025-07-17 Innospec Active Chemicals Llc Uses, methods and compositions
WO2025198136A1 (ko) * 2024-03-22 2025-09-25 주식회사 엘지생활건강 피부 장벽 강화용 조성물
CN119752844B (zh) * 2024-12-30 2025-11-07 上海其然生物科技有限公司 一种脂肪酶突变体及其用于生物催化制备二氢燕麦生物碱

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019754A (ja) 1983-07-14 1985-01-31 Kissei Pharmaceut Co Ltd 芳香族カルボン酸アミド誘導体の製造方法
US4673684A (en) 1984-04-04 1987-06-16 Terumo Corporation Amide derivatives and 5-lipoxygenase inhibitors containing the same as an active ingredient
HU200996B (en) 1988-05-23 1990-09-28 Biogal Gyogyszergyar Process for producing n-(3', 4'-dimethoxycinnamoyl)-anthranilic acid (tranilast)
DE19515609C1 (de) * 1995-04-28 1996-03-28 Kao Corp Gmbh Mittel zur Behandlung und Pflege von Haaren und Kopfhaut
US6127392A (en) 1997-08-05 2000-10-03 American Home Products Corporation Anthranilic acid analogs
US6096770A (en) 1998-08-03 2000-08-01 American Home Products Corporation Anthranilic acid analogs
DE10254872A1 (de) * 2002-11-25 2004-06-03 Symrise Gmbh & Co. Kg Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe
WO2007062957A1 (en) * 2005-11-30 2007-06-07 Symrise Gmbh & Co. Kg Mixtures comprising anthranilic acid amides and antidandruff agents as cosmetic and pharmaceutical compositions for alleviating itching
US20100267662A1 (en) * 2007-11-08 2010-10-21 Ceapro, Inc. Avenanthramide-containing compositions
US20170027852A1 (en) * 2015-07-30 2017-02-02 Truth Aesthetics LLC Topical Skin Care Composition For Day Use
US9636292B2 (en) * 2015-07-30 2017-05-02 Truth Aesthetics LLC Topical skin care composition for night use
WO2017159964A1 (ko) 2016-03-16 2017-09-21 전남대학교산학협력단 귀리 추출물을 유효성분으로 포함하는 난청의 예방 또는 치료용 약제학적 조성물
EP3664772B1 (en) * 2017-08-09 2024-03-20 Symrise AG 1,2-alkanediols and a process for their production
WO2019179639A1 (en) * 2018-03-23 2019-09-26 Symrise Ag Skin condition improving agents
CN109984957A (zh) * 2019-04-17 2019-07-09 李熙平 一种美白祛斑面膜液及其制备方法
CN110478444A (zh) * 2019-08-29 2019-11-22 深圳市兰亭科技股份有限公司 一种燕麦总生物碱及一种抗皮肤过敏的组合物及其制备方法

Also Published As

Publication number Publication date
JP2023516453A (ja) 2023-04-19
CA3172770A1 (en) 2021-09-10
EP4114348A1 (en) 2023-01-11
CN115209864A (zh) 2022-10-18
JP2025013865A (ja) 2025-01-28
WO2021175453A1 (en) 2021-09-10
KR102808076B1 (ko) 2025-05-15
KR20220151190A (ko) 2022-11-14
BR112022017573A2 (pt) 2022-10-18
US20230131993A1 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
MX2022010964A (es) Composicion que comprende una avenantramida o un analogo de la misma con estabilidad mejorada.
Aghebati-Maleki et al. Antibacterial, antiviral, antioxidant, and anticancer activities of postbiotics: a review of mechanisms and therapeutic perspectives
Bhargava et al. Experimental evidence for therapeutic potentials of propolis
Zong et al. Resveratrol inhibits LPS-induced MAPKs activation via activation of the phosphatidylinositol 3-kinase pathway in murine RAW 264.7 macrophage cells
Guo et al. Anti-inflammatory potential of native Australian herbs polyphenols
Catalano et al. Are nutraceuticals effective in COVID-19 and post-COVID prevention and treatment?
Vítor et al. Alternative therapies for Helicobacter pylori: probiotics and phytomedicine
Taveira et al. Lycopersicon esculentum seeds: an industrial byproduct as an antimicrobial agent
CL2020001312A1 (es) Composiciones de cannabidiol y usos de las mismas. (divisional solicitud 201803425).
BRPI0820068B8 (pt) uso de cepa de levedura e/ou de uma composição compreendendo cepa de levedura para preparação de um medicamento
MX385569B (es) Fitocomplejos que exhiben actividades antioxidantes sinérgicas, múltiples, útiles en alimentos, suplementos alimenticios, cosméticos y preparaciones farmacéuticas.
BR112022025416A2 (pt) Proteína doce de trufa
SA519401933B1 (ar) تركيبات صيدلية تحتوي على الأنسولين
BR112022008497A2 (pt) Derivados terapêuticos da interleucina-22
CO2021013251A2 (es) Derivados de insulina sensibles a la glucosa
BR112021025665A2 (pt) Uma preparação que compreende um composto de calixareno e o uso médico do mesmo, alimento, ração ou composição cosmética que compreende um composto de calixareno
Gámez et al. Effect of E-beam treatment on the chemistry and on the antioxidant activity of lycopene from dry tomato peel and tomato powder
BR112022004674A2 (pt) Ácido canforsulfônico e combinações do mesmo com excipientes catiônicos como agentes de redução de viscosidade em formulações de proteína altamente concentradas
AR063891A1 (es) Composicion para ser usada en productos alimenticios, preparados nutricionales, nutraceuticos y farmaceuticos
MX2021008812A (es) Composicion cosmetica/dermatologica.
WO2019239215A3 (en) Development of health food supplements and antioxidants for controlling hyperuricemia and oxidative stress
BR112017019831A2 (pt) uso de composições de astaxantina, composição, e, processo para preparação de alimento ou alimento animal
MX2022010948A (es) COMPOSICIÓN O EXTRACTO DE AVENA QUE COMPRENDE AVENANTRAMIDA Y ß-GLUCANO.
DOP2021000069A (es) Derivados de 4 pirazin-2-ilmetil-morfolina y su uso como medicamento
MX2022010949A (es) Composiciones de avenantramida con solubilidad mejorada que comprenden 4-hidroxifenona.